BDSX.NASDAQBiodesix INC

Form 4: Bio-Rad Laboratories Executive Chris Vazquez Reports Stock Sales to Cover Taxes on Vesting RSUs

Sentiment:

SEC Form 4 Filing


Chris Vazquez, Chief Accounting Officer of Bio-Rad Laboratories (BDSX), reported the sale of common stock to cover taxes upon the vesting of restricted stock units (RSUs).

Summary

  • Chris Vazquez, the Chief Accounting Officer of BIODESIX INC (BDSX), filed a Form 4 detailing changes in beneficial ownership.
  • On May 9, 2025, Vazquez acquired 602 shares of common stock through the vesting of restricted stock units (RSUs).
  • Vazquez sold 112 shares on May 12, 2025, at a weighted average price of $0.3594 to cover taxes upon the vesting of RSUs.
  • An additional 112 shares were sold on May 13, 2025, at a weighted average price of $0.3529 for the same purpose.
  • Following these transactions, Vazquez directly owns 18,001 shares of common stock and 1,805 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions for tax purposes, indicating a neutral sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

  • The stock sales may have a minor dilutive effect on existing shareholders, but the impact is likely minimal given the small number of shares involved.

Key Dates

DateDescription
02/08/2022Date from which RSUs vest in quarterly installments.
05/09/2025Acquisition of 602 shares through RSU vesting.
05/12/2025Sale of 112 shares at $0.3594 average price.
05/13/2025Sale of 112 shares at $0.3529 average price.

Keywords

Form 4, Beneficial Ownership, BIODESIX INC, BDSX, Chris Vazquez, Restricted Stock Units, RSU, Stock Sale, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.